Publication:
The Evaluation of Central Corneal Thickness and Intraocular Pressure in Conjunction With Tear IGF-1 Levels in Patients With Acromegaly

dc.authorscopusid55581347100
dc.authorscopusid55537171600
dc.authorscopusid14619488600
dc.contributor.authorKan, E.
dc.contributor.authorKan, E.K.
dc.contributor.authorOkuyucu, A.
dc.date.accessioned2020-06-21T13:18:24Z
dc.date.available2020-06-21T13:18:24Z
dc.date.issued2017
dc.departmentOndokuz Mayıs Üniversitesien_US
dc.department-temp[Kan] Emrah,; [Kan] Elif Kiliç, Department of Endocrinology & Metabolism, Samsun Training and Research Hospital, Samsun, Samsun, Turkey; [Okuyucu] Ali, Department of Biochemistry, Ondokuz Mayis Üniversitesi, Samsun, Turkeyen_US
dc.description.abstractPurpose: To compare the central corneal thickness (CCT), intraocular pressure (IOP), and tear insulin-like growth factor 1 (IGF-1) levels between patients with acromegaly and a control group and to evaluate the possible effect of tear IGF-1 and duration of the disease on CCT and IOP. Methods: We included 31 patients with acromegaly (study group) and 40 age- and sex-matched controls in the study. Patients with acromegaly were divided into 2 subgroups based on disease status (active/inactive). All participants underwent complete ophthalmologic evaluation including CCT and IOP values. Basal tear samples were collected from both groups and tear IGF-1 levels were measured. The CCT, IOP, and tear IGF-1 levels were compared between groups and subgroups and the association between tear IGF-I levels and ocular parameters (CCT, IOP) and disease duration were also evaluated. Results: Central corneal thickness, IOP, and tear IGF-1 levels did not show a significant difference between study and control groups. We also did not find a significant difference in terms of CCT, IOP, or tear IGF-1 levels between subgroups of patients. Correlation analysis did not show an association between the duration of disease and tear IGF-1 levels with CCT or IOP. Conclusions: There was no significant difference in tear IGF-1 levels between patients with acromegaly and controls. Additionally, there was no correlation between disease duration and tear IGF-1 levels with CCT or IOP levels. This lack of association may suggest that tear IGF-1 levels might not have an effect on CCT or IOP findings in patients with acromegaly. © 2017 Wichtig Publishing.en_US
dc.identifier.doi10.5301/ejo.5000932
dc.identifier.endpage534en_US
dc.identifier.issn1120-6721
dc.identifier.issn1724-6016
dc.identifier.issue5en_US
dc.identifier.pmid28127733
dc.identifier.scopus2-s2.0-85028714679
dc.identifier.scopusqualityQ2
dc.identifier.startpage531en_US
dc.identifier.urihttps://doi.org/10.5301/ejo.5000932
dc.identifier.volume27en_US
dc.identifier.wosWOS:000415309800007
dc.identifier.wosqualityQ3
dc.language.isoenen_US
dc.publisherWichtig Publishing Srl jean.jones@wichtig.comen_US
dc.relation.ispartofEuropean Journal of Ophthalmologyen_US
dc.relation.journalEuropean Journal of Ophthalmologyen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectAcromegalyen_US
dc.subjectCentral Corneal Thicknessen_US
dc.subjectInsulin-Like Growth Factoren_US
dc.subjectIntraocular Pressureen_US
dc.subjectTear Collectionen_US
dc.titleThe Evaluation of Central Corneal Thickness and Intraocular Pressure in Conjunction With Tear IGF-1 Levels in Patients With Acromegalyen_US
dc.typeArticleen_US
dspace.entity.typePublication

Files